Adaptive Biotechnologies is trading 4.15% higher at $26.87, a move that appears consistent with the broad market rally as election uncertainty eased.
- Major U.S. indexes were sharply higher, and reports described health-care shares as among the sectors gaining.
- No clear company-specific announcement explaining the intraday rise surfaced in the search.
- Third-quarter results were scheduled for after the market close and were not yet available to explain the move.